Rapid Nutrition Kicks Off 2025 with Strong Q1 Performance, Expanding China Growth, New Product Launch, and UK Market Entry
Localised Manufacturing Strategy Mitigates Tariff Risk and Powers Global Momentum
London, United Kingdom – 8 April 2025 – Rapid Nutrition PLC (Euronext Growth: ALRPD), a HealthTech company committed to advancing global wellness, has delivered a focused and high-execution first quarter—laying a solid foundation for accelerated growth in 2025 across key international markets.
Eighteen months ago, the Company made a strategic decision to manufacture locally in core markets—a move that is proving highly effective amid newly implemented U.S. tariffs. By localising production in both China and the United States, Rapid Nutrition has mitigated geopolitical risk, reduced costs, and enabled faster, more flexible market delivery.
“We implemented local manufacturing early as part of a long-term global strategy—not just to reduce costs, but to increase resilience,” said CEO Simon St. Ledger. “Now, with trade policies shifting, that foresight is translating into clear operational and financial advantages.”
Q1 Highlights:
China Growth Accelerates
Building on January's strong performance—1,245 orders and a 4,100% increase versus prior periods, with an AOV of ¥102.30—China continues to show month-on-month growth. This consistent upward trend is driving significant incremental revenue in 2025. With brand recognition and customer acquisition expanding, additional products will be introduced in H2 to capture further market share.
- U.S. Subscription Model Readies for Launch
The Q4 2024 inventory scale-up, executed as part of the company’s forward-looking demand planning, has proven particularly well-timed in light of newly enacted tariffs. This proactive positioning affords Rapid Nutrition a unique operational and commercial advantage—enabling the seamless rollout of its U.S. subscription model while safeguarding margins and supply continuity. Local manufacturing further insulates the business from trade disruptions and enhances customer fulfilment efficiency. - UK Market Entry Underway
The recently launched Brand Ambassador Program has exceeded early expectations, with over 100 participants already engaged. Due to the success of this initiative, management is advancing discussions with the company’s global fulfilment partner to implement a similar program across the UK and broader European markets later this year. This phased approach supports strategic expansion while leveraging proven engagement models in new regions. - New Product Launch
A new product will be released this quarter to meet rising demand, reinforcing the company’s innovation pipeline and readiness for scale across retail and DTC channels.
Strategic Momentum for 2025
“We’ve entered the year with a leaner cost base, clearer execution, and infrastructure aligned for growth,” added St. Ledger. “With strong demand signals, scalable operations, and increasing global brand traction, we are well-positioned to deliver on our growth strategy.”
About Rapid Nutrition
Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).